Phase 3 E. Coli
Vaccine Study

Now Open in Binghamton and Vestal

Escherichia coli (E. coli) are bacteria that can cause infections, which can trigger diarrhea, nausea, vomiting, and fever. In some cases, the infection can be life-threatening. While E. coli can affect people of all ages, people age 60 and older are more susceptible to becoming ill from the bacteria, especially those with a history of urinary tract infections (UTIs).

Meridian is now seeking participants ages 60 and older with a history of UTI for an investigational E. coli vaccine study.

Eligible participants…

  • Must be ages 60 or older
  • Must have had a documented case of UTI within the past 2 years
  • Will receive compensation for study-related time
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.

You can also talk to a Meridian enrollment specialist about this study by calling (912) 623-2240.

Expect Excellence icon - supporting research since 1999

Submit your information

Study Locations

New York

  • Binghamton: Meridian Clinical Research, 1130 Upper Front St., Binghamton, NY 13905
  • Vestal: Meridian Clinical Research, 4100 Vestal Road, Ste LL-100, Vestal, NY 13850

Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.